S'abonner

The incremental value of bronchoalveolar lavage for the diagnosis of pulmonary tuberculosis in a high-burden urban setting - 01/06/19

Doi : 10.1016/j.jinf.2019.05.009 
Ping Xu a, b, 1, Peijun Tang c, 1, Huafeng Song a, b, 1, Jing Zhao a, b, Hui Chen a, b, Jing Xue a, b, Yunxia Zhai a, b, Yu Pang a, d, , Meiying Wu a, b, c,
a Department of Clinical Laboratory, The Fifth People's Hospital of Suzhou, Infectious Disease Hospital Affiliated to Soochow University, No. 10, Guangqian Road, Xiangcheng District, Suzhou 215000, China 
b The Key Laboratory of Infection and Immunity of Suzhou City, Suzhou, China 
c Department of Tuberculosis, The Fifth People's Hospital of Suzhou, Infectious Disease Hospital Affiliated to Soochow University, Suzhou, China 
d National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital affiliated to Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, No 9, Beiguan Street, Tongzhou District, Beijing 101149, China 

Corresponding author at: National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital affiliated to Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, No 9, Beiguan Street, Tongzhou District, Beijing 101149, China.National Clinical Laboratory on TuberculosisBeijing Chest Hospital affiliated to Capital Medical UniversityBeijing Tuberculosis and Thoracic Tumor Research InstituteNo 9, Beiguan Street, Tongzhou DistrictBeijing101149China⁎⁎Corresponding author at: Department of Clinical Laboratory, The Fifth People's Hospital of Suzhou, Infectious Disease Hospital Affiliated to Soochow University, No. 10, Guangqian Road, Xiangcheng District, Suzhou 215000, ChinaDepartment of Clinical LaboratoryThe Fifth People's Hospital of SuzhouInfectious Disease Hospital Affiliated to Soochow UniversityNo. 10, Guangqian Road, Xiangcheng DistrictSuzhou215000China

Summary

Objectives

We prospectively evaluated the use of bronchoalveolar lavage fluid (BALF) specimens to assess their added incremental value to pulmonary tuberculosis (TB) diagnostic strategies used currently in a high-burden urban setting in China.

Methods

A prospective study was conducted of patients with presumptive pulmonary TB registered at the Fifth Hospital of Suzhou between March 2018 and July 2018. BALF samples from patients with initial Xpert-negative sputum results were tested to diagnose TB.

Results

Of 440 participants, 316 (71.8%) were initially diagnosed with TB from sputum, including 245 (55.7%) definitive TB cases based on a positive culture and/or Xpert result(s) and 71 (16.1%) positive cases based on clinical diagnosis. Of 153 patients with initial positive cultures, a significantly higher proportion were confirmed as TB-positive using Xpert (94.1%) versus smear microscopy (45.8%, P < 0.01). Xpert testing of BALF from 182 Xpert-negative cases exhibited greater detection sensitivity (97.4%) than did smear microscopy (23.4%, P < 0.01). Meanwhile, 74.1% of TB patients initially diagnosed as TB-negative via smear microscopy were identified using Xpert testing of BALF at reduced diagnostic cost/patient (from USD 266.9 to 171.5).

Conclusions

BALF samples added incremental value to pulmonary TB diagnostic strategies for patients with Xpert-negative sputum. Xpert outperformed smear microscopy for tubercle bacilli detection in both sputum and BALF.

Le texte complet de cet article est disponible en PDF.

Keywords : Tuberculosis, Bronchoalveolar lavage, Xpert, Smear microscopy, Cost analysis


Plan


© 2019  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 79 - N° 1

P. 24-29 - juillet 2019 Retour au numéro
Article précédent Article précédent
  • Characterization of QuantiFERON-TB-Plus results in latent tuberculosis infected patients with or without immune-mediated inflammatory diseases
  • Teresa Chiacchio, Elisa Petruccioli, Valentina Vanini, Gilda Cuzzi, Umberto Massafra, Gianpiero Baldi, Assunta Navarra, Rossana Scrivo, Claudio Mastroianni, Ilaria Sauzullo, Carmela Esposito, Fabrizio Palmieri, Fabrizio Cantini, Delia Goletti
| Article suivant Article suivant
  • Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks
  • Anaïs Corma-Gómez, Juan Macías, Dolores Merino Muñoz, Francisco Téllez, Rafael Granados, Luis E. Morano, Ignacio De Los Santos Gil, Francisco J. Vera-Méndez, Antonio Collado, Rosario Palacios, Juan A. Pineda

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.